Electrophoresis

Under the Challenges of Climate Change, Zoomlion Advances Green Manufacturing and Renewable Energy

Retrieved on: 
Monday, November 20, 2023
United, Climate change, Electrophoresis, Engineering, R, United Nations Global Compact, Industrial park, United Nations, Renewable energy, Heavy equipment, VOC

The core of Zoomlion's green transformation roadmap is creating world-class eco-friendly products and building sustainable factories through the R&D and construction of green design, manufacturing, management, and standards.

Key Points: 
  • The core of Zoomlion's green transformation roadmap is creating world-class eco-friendly products and building sustainable factories through the R&D and construction of green design, manufacturing, management, and standards.
  • Green Manufacturing: as of June 2023, Zoomlion has put a total of five intelligent factories and 170 intelligent production lines into operation.
  • Green Management: Zoomlion has digitalized management through R&D, process, manufacturing, sales, services and more to establish a full-process, whole-chain evaluation methodology.
  • Green Products: as of December 2022, Zoomlion has launched 156 new energy equipment covering 13 product lines from engineering hosting machinery to agricultural machinery.

Under the Challenges of Climate Change, Zoomlion Advances Green Manufacturing and Renewable Energy

Retrieved on: 
Monday, November 20, 2023
United, Climate change, Electrophoresis, Engineering, Multimedia, R, United Nations Global Compact, Industrial park, United Nations, Renewable energy, Heavy equipment, VOC

The core of Zoomlion's green transformation roadmap is creating world-class eco-friendly products and building sustainable factories through the R&D and construction of green design, manufacturing, management, and standards.

Key Points: 
  • The core of Zoomlion's green transformation roadmap is creating world-class eco-friendly products and building sustainable factories through the R&D and construction of green design, manufacturing, management, and standards.
  • Green Manufacturing: as of June 2023, Zoomlion has put a total of five intelligent factories and 170 intelligent production lines into operation.
  • Green Management: Zoomlion has digitalized management through R&D, process, manufacturing, sales, services and more to establish a full-process, whole-chain evaluation methodology.
  • Green Products: as of December 2022, Zoomlion has launched 156 new energy equipment covering 13 product lines from engineering hosting machinery to agricultural machinery.

Proteomics Reagents Dominate Market, While Drug Discovery Applications Exhibit Highest Growth Rate - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 1, 2023
Biotechnology, Pharmaceutical, Health, Research, Growth, Proteomics, Chromatography, Government, Drug discovery, Prevalence, End, Protein microarray, Developed country, Protein, R, Artificial intelligence, Genomics, COVID-19, DSM-IV codes, Hospital, Traction, TAT, Surface plasmon resonance, Instrument, Patient, Medical device, Pharmaceutical industry, Fine chemical, Electrophoresis, Investment, Cancer

Faster Turn-around Times (TAT): Proteomics technologies enable faster turn-around times in diagnostics and drug discovery, facilitating quicker patient management and pharmaceutical development.

Key Points: 
  • Faster Turn-around Times (TAT): Proteomics technologies enable faster turn-around times in diagnostics and drug discovery, facilitating quicker patient management and pharmaceutical development.
  • Increased Investments in R&D in the Field of Proteomics: Research and development activities in proteomics have witnessed significant investments, driving innovation and market growth.
  • Surge in Drug Discovery: Proteomics technologies are increasingly being used to accelerate drug discovery processes, leading to the development of novel therapeutic agents.
  • The drug discovery segment is also expected to exhibit the highest CAGR in the future, as proteomics technologies offer early insights into drug discovery programs, saving pharmaceutical companies significant capital and benefiting patients and healthcare systems.

Labroots' CRISPR Conference Marks 6 years of CRISPR Engineering and Beyond - November 1, 2023

Retrieved on: 
Thursday, October 26, 2023
Kavli Institute of Nanoscience, Q&A, Intelligence, Microfluidics, Genomics, Electrophoresis, Southern University of Science and Technology, FRS, CRISPR, University, Research, Engineering, Kavli Foundation (United States), Biology, Networking hardware, Medicine, Kidney disease, Melissa Chaty, University of Oxford, Biomedicine, Biomedical engineering, POC, DNA, Pharmaceutical industry, Vaccine, Genetics, Fellow of the Royal Academy of Engineering, Southern University, News, Biotechnology, Diagnosis

YORBA LINDA, Calif., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 6th annual event in the CRISPR Virtual Event Series, hosted on November 1, 2023. The free event runs the gamut of cutting-edge scientific breakthroughs and current research that promises to uncover the ever-evolving innovative approaches in sessions devoted to CRISPR Biology and Biotechnology, CRISPR in Diagnostics, and CRISPR in Disease Therapy.

Key Points: 
  • The free event runs the gamut of cutting-edge scientific breakthroughs and current research that promises to uncover the ever-evolving innovative approaches in sessions devoted to CRISPR Biology and Biotechnology, CRISPR in Diagnostics, and CRISPR in Disease Therapy.
  • CRISPR 2023 will bring together bioengineers, top scientists, research scholars, and key stakeholders who will deliver academic and industry perspectives on the accomplishments and promise of CRISPR-based techniques while sharing the latest intelligence in the field.
  • Dr. Xingyu Jiang, Chair Professor of Biomedical Engineering at the Southern University of Science and Technology, discusses microfluidics and CRISPR-Diagnostics/Therapy with a live Q&A session.
  • Now, you can also join our professional community on LinkedIn by being a part of the Genetics & Genomics group!

Revolutionizing Vehicle Interactions: Automotive Displays Market to Transform Driver-Vehicle Interface from 2024 to 2034 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023
Vehicle Technology, Automotive, Pillar, CGH, Digital divide, Computer-generated holography, Electroluminescence, USB On-The-Go, Visteon, Stroboscopic effect, TCL, Quantum dot, OLED, LG Display, Contact lens, Autonomy, LFD, WayRay, Privacy, LCD, TFT-LCD, HUD (video gaming), EVS, Continental, Market, Hyundai, SLM, Advanced driver-assistance system, Samsung Display, Hyundai Mobis, Glass, ADAS, Electrophoresis, Safety, Apple Thunderbolt Display, Instrumentation, Mobile phone, Television, Buick Envision

The global automotive displays market is undergoing a transformative phase, bringing cutting-edge display technologies to the automotive industry.

Key Points: 
  • The global automotive displays market is undergoing a transformative phase, bringing cutting-edge display technologies to the automotive industry.
  • Display Technologies Reshaping Automotive Interfaces:
    Automotive displays have emerged as the pivotal interface between drivers and vehicles, facilitating not only vital information but also entertainment.
  • This market encompasses a diverse array of display technologies, including Liquid Crystal Displays (LCD), Organic Light Emitting Diode (OLED), Thin Film Transistor LCD (TFT-LCD), Thin-film electroluminescent (TFEL) displays, Head-Up Displays (HUDs), 3D displays, Computer-Generated Holography (CGH), Light Field Displays (LFD), Spatial Light Modulators (SLM), flexible displays, transparent displays, curved displays, and more.
  • These include Continental, Envisics, Hyundai Mobis, LG Display, Samsung Display, TCL, Visteon, WayRay, and many more, showcasing the innovative leaders shaping the future of automotive displays.

Advancing Safety and Autonomy: The Role of Displays in ADAS and Autonomous Driving - A Look at Key Market Trends and Technologies

Retrieved on: 
Wednesday, September 13, 2023
Pillar, CGH, Digital divide, Computer-generated holography, Electroluminescence, USB On-The-Go, Visteon, Stroboscopic effect, TCL, Quantum dot, OLED, LG Display, Contact lens, Autonomy, LFD, WayRay, Privacy, LCD, TFT-LCD, HUD (video gaming), EVS, Continental, Market, Hyundai, SLM, Advanced driver-assistance system, Samsung Display, Hyundai Mobis, Glass, ADAS, Electrophoresis, Safety, Apple Thunderbolt Display, Satellite navigation device, Instrumentation, Mobile phone, Television, Buick Envision

The global automotive displays market is undergoing a transformative phase, bringing cutting-edge display technologies to the automotive industry.

Key Points: 
  • The global automotive displays market is undergoing a transformative phase, bringing cutting-edge display technologies to the automotive industry.
  • Display Technologies Reshaping Automotive Interfaces:
    Automotive displays have emerged as the pivotal interface between drivers and vehicles, facilitating not only vital information but also entertainment.
  • This market encompasses a diverse array of display technologies, including Liquid Crystal Displays (LCD), Organic Light Emitting Diode (OLED), Thin Film Transistor LCD (TFT-LCD), Thin-film electroluminescent (TFEL) displays, Head-Up Displays (HUDs), 3D displays, Computer-Generated Holography (CGH), Light Field Displays (LFD), Spatial Light Modulators (SLM), flexible displays, transparent displays, curved displays, and more.
  • As electric vehicles (EVs) and autonomous driving take center stage, the role of vehicle-mounted displays is expanding.

Global Cell and Gene Therapy Manufacturing QC Market Expected to Reach $10.65 Billion by 2033, Witnessing a CAGR of 16.85% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 16, 2023
Biotechnology, Genetics, Health, Gene, QC, NGS, Sartorius AG, Chromatography, Merck Group, MEA, Medicine, Research, Mass spectrometry, ELISA, Organization, Information International, Inc., CAR, QRM, Thermo Fisher Scientific, Patient safety, Flow cytometry, Kidney, Cell, PAT, LAL, Center for Urban and Regional Analysis, Electrophoresis, Therapy, Benchmarking, Eurofins Scientific, PCR, Safety, Automation, LATAM, Fine chemical, Pharmaceutical industry

The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is projected to reach $10.65 billion by 2033, with a CAGR of 16.85% during the forecast period from 2023 to 2033.
  • The demand for QC in cell and gene therapy manufacturing is driven by the growing production of therapies and increasing approvals for cell and gene therapies.
  • The global cell and gene therapy manufacturing QC market is on a growth trajectory, and key players are leveraging advancements in technology to drive improvements in product quality and safety.

New Study Demonstrates Efficient Exosome Isolation from Biological Fluids Using Proprietary Technology from Biological Dynamics

Retrieved on: 
Wednesday, July 26, 2023
Oncology, Medical Supplies, Health, Health Technology, Clinical Trials, Research, Science, Extracellular vesicle, Nanoparticle, Collection, Biological Dynamics of Forest Fragments Project Area of Relevant Ecological Interest, Doctor of Philosophy, Serum, Oregon Health & Science University, Exosome, Cancer, Cell, Biomarker, Electrophoresis, Biology, Plasma, Glossary of biology, MD, OHSU, Blood, Department of Computer Science, University of Manchester, ACE, Dielectrophoresis, Particle collection in wet scrubbers, Pharmaceutical industry, Medical imaging

Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in the journal Electrophoresis titled, “ Enhancement of Dielectrophoresis-Based Particle Collection from High Conducting Fluids Due to Partial Electrode Insulation.

Key Points: 
  • Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in the journal Electrophoresis titled, “ Enhancement of Dielectrophoresis-Based Particle Collection from High Conducting Fluids Due to Partial Electrode Insulation.
  • ” The collaborative research with Oregon Health & Science University (OHSU) sheds light on the phenomenon occurring on Biological Dynamics’ ExoVerita platform that allows for the capture of biomarkers carried by nanoscale particles.
  • Biological Dynamics’ proprietary lab-on-a-chip platform leverages AC Electrokinetics (ACE) technology for the isolation of exosomes from undiluted biofluids, such as whole blood, plasma, and serum.
  • "I look forward to seeing how the advancements we make with the technique improve the capability of diagnostic tools to detect and analyze diseases."

Global Life Science Instrumentation Market Report 2023: Sector is Expected to Reach $107.3 Billion by 2030 at a CAGR of 6.5% - ResearchAndMarkets.com

Retrieved on: 
Friday, June 16, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Vaccine, Prevalence, Software, Coalition, NGS, Chromatography, Diagnosis, Food quality, MEA, Research, Mass spectrometry, World Bank, USD, Government, Market, Agilent Technologies, Flow cytometry, Hospital, Laboratory, Application, Machine learning, Engineering, Plant growth analysis, Artificial intelligence, Conditional sentence, Virtual Control, Growth, AI, Microscopy, NYSE, PCR, Third-generation sequencing, Management, Medical device, Fine chemical, Health care, Electrophoresis

The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.

Key Points: 
  • The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.
  • Global life science instrumentation market is segmented based on technology, application, distribution channel and region.
  • Based on the application, the global life science instrumentation market is segmented into Clinical and Diagnostic, Research and Others.
  • The growth of the life science instrumentation market is being propelled by several factors including increased government spending in life science research and development in the biotechnology and life science sectors.

Global Proteomics Market Report 2023: Sector is Expected to Reach $100.17 Billion by 2030 at a CAGR of 16.55% - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 30, 2023
Health, Biotechnology, SPR, Chromatography, Proteomics, Prognosis, MEA, Genomics, Mass spectrometry, Protein, Biomarker, Drug discovery, Biology, Growth, Electrophoresis, Pharmaceutical industry, Medical imaging

The global proteomics market is driven by the increasing demand for personalized medicine, advancements in proteomics technologies, and the growing focus on drug discovery and development.

Key Points: 
  • The global proteomics market is driven by the increasing demand for personalized medicine, advancements in proteomics technologies, and the growing focus on drug discovery and development.
  • The global proteomics market is segmented based on the product, technology, application and region.
  • The proteomics market is expected to grow significantly due to various drivers, such as the increasing demand for personalized medicine.
  • The high cost of proteomics technologies is a major restraint for the growth of the proteomics market.